China in Africa

 

Pekings Sinogene etabliert Klonierungsservice für Beagles mit genetischen Erkrankungen als Versuchstiere

Sinogene ist es bereits 2016 gelungen, zwei genveränderte Beagles zu züchten, die leichter an Atherosklerose erkranken (Entfernung des Apolipoprotein E-Gens mit der CRISPR/Cas9-Methode). Am 28. Mai kam nun ein Beagle-Baby namens Longlong (Drache) zur Welt, der aus einer Körperzelle eines Beagle kloniert worden war (somatische Klonierung). Sinogene wird nun beide Methoden kombinieren und will weltweit einen Klonierungs- und Geneditier-Service für Beagle-Hunde als Krankheitsmodelle anbieten. Außerdem sollen Hundehalter in der Gen- und Zellbank des Unternehmens Zellen ihres Haustiers lagern und zu gegebener Zeit für Stammzell-Therapien an ihrem Vierbeiner nutzen können.

http://english.cas.cn/newsroom/news/201707/t20170707_179419.shtml

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Window-to-China

Overview of last view Blogs

China will start program on personalied medicine

The program, which is titled “precision medicine” in China, will be started in 2016 and based on a genome database of its population. It will be organized by the Chinese Academy of Medical Sciences under the auspices of academician ZHAN Qimin.

China Bio news release, August 11, 2015

China will soon launch Jilin-1, carrying 4 commercial satellites

Jilin-1 will consist of four satellites, one for high-definition images, one for testing new space technology and two for video transmissions. Jilin, with its capital Changchun, is one of the country’s oldest industrial bases and is developing its satellite industry as a new economic base.
The province is said to plan the launch of 60 satellites by 2020 and 137 by 2030.

CAS news release, August 11, 2015

Shanghai researchers convert fibroblasts from Alzheimer patient into neuronal cells

A team around PEI Gang at Shanghai’s CAS Institute of Biochemistry and Cell Biology found that human fibroblasts can be directly converted into neuronal cells by a chemical cocktail of seven small molecules. The chemical-induced neuronal cells (hciNs) were similar to hiPSC-derived neurons and TF-iNs with respect to morphology, gene expression profiles, and electrophysiological properties. The protocol was successfully applied to generate Alzheimer’s disease patient fibroblast derived neuronal cells for disease modeling.

CAS news release, August 7, 2015

CAS Insttute of Oceanology, Qingdao, succeeds to breed albino sea cucumbers, an expensive delicacy

Some years ago, five white sea cucumbers sold at an auction in the city of Jinan for 160,000 renminbi, or nearly $26,000 at today’s exchange rate. Based on the genome sequence of sea cucumbers, sold by this institute and others, the group of YANG Hongsheng succeeded in breeding 150 million white sea cucumbers suitable for aquaculture. In Chinese traditional medicine, sea cucumbers — which are called haishen (海参), or “sea ginseng,” in Chinese — are thought to improve skin texture, reduce high blood pressure and suppress cancer.

CAS news release, August 8, 2015

CAS publishes “Blue Book” on China’s International Competitiveness in basic sciences

Based on quantitative measures for scientific outpout, the authors conclude that China needs to strengthen basic science. Between 2009 and 2013, the number of papers grew by 80 %, but citations are still low (5.3 % of global citations). Global share of Chinese life sciences is only about 2%, while the US share in this subject is around 50%.

CAS news release, August 5, 2015

COFCO Nutrition and Health Research Institute wins MAKE award

The MAKE award (for Most Admired Knowledge Enterprise) was inaugurated in 1998 as a global research program seeking to identify those organizations which are out-performers by above average growth in intellectual capital and wealth creation. Global MAKE winners are, e. g., Apple, ConocoPhillips, Deloitte, Google, IBM, Novo Nordisk, SamsungGroup, SAP, Siemens, Tata Group, and Toyota. COFCO obtained the prize for job retention marks, for catalyzing innovation, delivering business value etc.

China Bio news release, August 4, 2015

China’s next 5-years-plan (135) for pharmaceutical industry seems ready

The focus will be on medical information including telemedicine information systems, hopsitals with improved management system, support of the medical device industry, in particular for high-end equipment, and enhanced R&D support for Chinese drug makers

China Bio news release, July 30, 2015

Shanghai opens National Center for Protein Science

The center is conceived as one of 12 large national science facilities and located in the Pudong area. Construction cost were 100 million Yuan. Since the start of trial operations in mid-2014, 3.500 researchers from 60 indstitutes and universities across China are said to have carried out experiments in this well-equipped institution already.

CAS news release, July 29, 2015

Tsinghua Holdings and Baoji High-Tech Zone in Beijing sign strategic agreement to build 1.3 billion Yuan S&T Park

The partners will offer space and technology from China’s leading university in various fields of information technology, environmental protection, life science, technology services and knowledge industries, the Internet industry, biomedicine, new energy development, intelligent manufacturing, machinery and electronics, offering intellectual support from talents.

China Bio news release, July 27, 2015

China’s bioindustry maintains 20 % annual growth: Wan Gang

At the 2015 International Conference for Bioeconomy held in Dalian, MOST chef Wan Gang held that the output of China’s bioindustry reached 3,16 trillion Yuan (510 billion USD) in 2014 and will show further strong growth.

China Bio news release, July 27, 2015

Taiwan’s Bioindustry is thriving

Bio Taiwan 2015 (July 23 – 26, 2015) shows a blooming industry sector with 288,6 billion NT $ turnover (8.5 billion €), strong growth and investment. Acording to President MA Yingjeou, Taiwan now boasts over 1600 biotech companies or 2,16 % of all listed companies.

China Bio news release, July 24, 2015